RICHMOND, Va., Feb. 7 -- Rep. Eric I. Cantor, R-Va. (7th CD), issued the following news release:
Congressman Eric Cantor (VA-7) today toured kaleo, a local pharmaceutical company that develops lifesaving personal medical products and participated in a roundtable discussion with local patient advocates and their families who have benefitted from innovative medical research and technology:
"Prioritizing medical research and innovation is critical to helping patients, finding cures and treatments, and ultimately lowering health care costs. In the House of Representatives we will build upon the successes of the pediatric research networks included in the PREEMIE Act and the Gabriella Miller Kids First Research Act. This year, we will continue our work in Congress by advancing another proposal to eliminate wasteful federal programs and reallocate funds toward lifesaving research at NIH. Richmond area innovators like kaleo, Virginia Bio and Virginia Biotechnology Research Park are on the forefront of developing lifesaving technology to help more people. I look forward to continuing to hear from Seventh District patients, as well as the medical community, as we work on additional ways to advance medical research and discovery."
Spencer Williamson, CEO of kaleo, added, "kaleo hosted a patient summit because listening to patients is at the core of everything we do. Patients are experts on how their medical condition impacts their lives. It's with that philosophy in mind that kaleo is developing next generation lifesaving personal medical products , and we're glad it's a philosophy Congressman Cantor shares with us."
TNS 30TacordaCheng-140208-4631211 30TacordaCheng